SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D17E526F33F36F86C9CD1F32346530C210C86097C36DE7588A43A4D00C78A83D338FEE999C5578192F5B6CDF105AE2F3>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D17E526F33F36F86C9CD1F32346530C210C86097C36DE7588A43A4D00C78A83D338FEE999C5578192F5B6CDF105AE2F3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D17E526F33F36F86C9CD1F32346530C210C86097C36DE7588A43A4D00C78A83D338FEE999C5578192F5B6CDF105AE2F3
http://www.w3.org/2000/01/rdf-schema#comment
"Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro."
xsd:string
http://purl.uniprot.org/uniprot/#_F718AA94605CDF5FDC96241BA1653A55D80EDD008D5B12A1F523F3F6F292D590EFFE98C23D9B91B230F8E5AC05E049A0
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D17E526F33F36F86C9CD1F32346530C210C86097C36DE7588A43A4D00C78A83D338FEE999C5578192F5B6CDF105AE2F3
http://purl.uniprot.org/uniprot/B4DEK3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D17E526F33F36F86C9CD1F32346530C210C86097C36DE7588A43A4D00C78A83D338FEE999C5578192F5B6CDF105AE2F3
http://purl.uniprot.org/uniprot/#_B4DEK3-mappedCitation-34058069
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D17E526F33F36F86C9CD1F32346530C210C86097C36DE7588A43A4D00C78A83D338FEE999C5578192F5B6CDF105AE2F3